Trial Outcomes & Findings for Early Administration of Steroids in the Ambulance Setting (NCT NCT03962894)

NCT ID: NCT03962894

Last Updated: 2025-05-08

Results Overview

Number of admissions to an inpatient unit (general or ICU) for an asthma exacerbation

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

834 participants

Primary outcome timeframe

Day 1 (ED stay)

Results posted on

2025-05-08

Participant Flow

There was no recruitment, as this was an observational study of patients who were receiving EMS treatment regardless of the study.

EMS agencies who decided to incorporate oral systemic corticosteroids as part of clinical care were for this study. The study assigned the start date for EMS agencies to include oral systemic corticosteroids. For the purpose of analysis, we treated that as a stepped wedge protocol design. All agencies contributed one year of data for early prehospital systemic corticosteroids, and one year of data for no prehospital systemic corticosteroids.

Unit of analysis: EMS agencies

Participant milestones

Participant milestones
Measure
Houston EMS Pre and Post-Protocol Change
Children with asthma attacks treated by Houston EMS. Data abstracted 12 months before and 12 months after protocol change adding oral systemic corticosteroids that occurred on 10/1/2014.
Cincinnati EMS Pre- and Post-Protocol Change
Children with asthma attacks treated by Cincinnati EMS. Data abstracted 12 months before and 12 months after protocol change adding oral systemic corticosteroids that occurred on 1/1/2016.
Nassau County FL EMS Pre- and Post- Protocol Change
Children with asthma attacks treated by Nassau County FL EMS. Data abstracted 12 months before and 12 months after protocol change adding oral systemic corticosteroids that occurred on 6/1/2019.
Lee County FL EMS Pre- and Post- Protocol Change
Children with asthma attacks treated by Lee County FL EMS. Data abstracted 12 months before and 12 months after protocol change adding oral systemic corticosteroids that occurred on 11/1/2019.
Walton County FL EMS Pre- and Post-Protocol Change
Children with asthma attacks treated by Walton County FL EMS. Data abstracted 12 months before and 12 months after protocol change adding oral systemic corticosteroids that occurred on 11/1/2020.
Leon County FL EMS Pre- and Post-Protocol Change
Children with asthma attacks treated by Leon County FL EMS. Data abstracted 12 months before and 12 months after protocol change adding oral systemic corticosteroids that occurred on 2/1/2021.
Sarasota County FL EMS Pre- and Post-Protocol Change
Children with asthma attacks treated by Sarasota County FL EMS. Data abstracted 12 months before and 12 months after protocol change adding oral systemic corticosteroids that occurred on 6/1/2021/
Overall Study
STARTED
265 1
271 1
6 1
133 1
14 1
99 1
46 1
Overall Study
COMPLETED
265 1
271 1
6 1
133 1
14 1
99 1
46 1
Overall Study
NOT COMPLETED
0 0
0 0
0 0
0 0
0 0
0 0
0 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Early Administration of Steroids in the Ambulance Setting

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Early Prehospital Systemic Corticosteroids
n=175 Participants
Children with asthma attacks who receive systemic corticosteroids in the prehospital environment by emergency medical services Prednisolone: During a sequenced rollout protocol change for several EMS agencies, those agencies will adopt protocol change to administer prednisolone to children with asthma attacks in the prehospital environment prior to ED arrival.
Usual Care
n=659 Participants
Children with asthma attacks treated by emergency medical services who receive usual care en route to emergency departments, where in the ED they then receive systemic corticosteroids
Total
n=834 Participants
Total of all reporting groups
Age, Continuous
8 years
n=5 Participants
8 years
n=7 Participants
8 years
n=5 Participants
Sex: Female, Male
Female
67 Participants
n=5 Participants
381 Participants
n=7 Participants
448 Participants
n=5 Participants
Sex: Female, Male
Male
108 Participants
n=5 Participants
278 Participants
n=7 Participants
386 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
107 Participants
n=5 Participants
417 Participants
n=7 Participants
524 Participants
n=5 Participants
Race (NIH/OMB)
White
37 Participants
n=5 Participants
146 Participants
n=7 Participants
183 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
29 Participants
n=5 Participants
92 Participants
n=7 Participants
121 Participants
n=5 Participants
Bronchodilator Administered
159 Participants
n=5 Participants
529 Participants
n=7 Participants
688 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 1 (ED stay)

Number of admissions to an inpatient unit (general or ICU) for an asthma exacerbation

Outcome measures

Outcome measures
Measure
Early Prehospital Systemic Corticosteroids
n=175 Participants
Children with asthma attacks who receive systemic corticosteroids and bronchodilators in the prehospital environment by emergency medical services
No Early Prehospital Systemic Corticosteroids
n=659 Participants
Children with asthma attacks treated by emergency medical services who receive bronchodilators en route to emergency departments, where in the ED they then receive systemic corticosteroids
Hospital Admission
57 Participants
208 Participants

SECONDARY outcome

Timeframe: Day 1 (from EMS arrival to ED disposition)

Length of time in emergency department for patients from arrival to disposition (i.e., length of time for discharge, admission, or transfer to another hospital)

Outcome measures

Outcome measures
Measure
Early Prehospital Systemic Corticosteroids
n=175 Participants
Children with asthma attacks who receive systemic corticosteroids and bronchodilators in the prehospital environment by emergency medical services
No Early Prehospital Systemic Corticosteroids
n=659 Participants
Children with asthma attacks treated by emergency medical services who receive bronchodilators en route to emergency departments, where in the ED they then receive systemic corticosteroids
Emergency Department Length-of-stay
168 minutes
Interval 127.0 to 256.0
159 minutes
Interval 108.0 to 228.0

Adverse Events

Early Prehospital Systemic Corticosteroids

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

No Early Prehospital Systemic Corticosteroids

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jennifer Fishe

University of Florida

Phone: 904-244-4046

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place